FRT4D - Overview: T4 (Thyroxine), Free, Dialysis, Serum
Determining thyroid status of sick, hospitalized patients Determining thyroid status of patients in whom abnormal binding proteins have been identified Possibly useful in pediatric patients
YMCRO - Overview: Y Chromosome Microdeletions, Molecular Detection, Varies
Evaluating men with azoospermia, severe oligozoospermia, or otherwise unexplained male factor infertility
Detecting in utero drug exposure up to 5 months before birth Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen by...
TIUCR - Overview: Titanium/Creatinine Ratio, Random, Urine
Monitoring exposure and elimination of titanium
FCDU2 - Overview: Benzodiazepines, Umbilical Cord Tissue
Benzodiazepines, Umbilical Cord Tissue
ZW347 - Overview: Miscellaneous Blueprint Genetics Inc.
Miscellaneous Blueprint Genetics Inc.
ZW346 - Overview: Miscellaneous Cleveland Clinic
Miscellaneous Cleveland Clinic
ZW321 - Overview: Miscellaneous Next Molecular Analytics
Miscellaneous Next Molecular Analytics
PEPAN - Overview: Comprehensive Peripheral Neuropathy Gene Panel, Varies
Establishing a molecular diagnosis for patients with peripheral neuropathy Identifying variants within genes known to be associated with peripheral neuropathy, allowing for predictive testing of at-risk family members
GNPFD - Overview: Platelet Function Defect Gene Panel, Next-Generation Sequencing, Varies
Diagnosing hereditary platelet function defect disorders for patients who have a distinct platelet function defect pattern, such as Bernard-Soulier syndrome, revealed by laboratory phenotypic testing Confirming a hereditary platelet...
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....